This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up to the end of February 2019 (EMCDDA)
Bibliography: Interventions – Treatment
Drug-Related Hospital Statistics Scotland 2017/18
This report describes the number of drug-related hospital stays, the number and characteristics of patients admitted to hospital, the substances involved and the geographical variations within Scotland (ISD)
Alcohol and other drug treatment services in Australia 2017–18: key findings
In 2017–18, 952 publicly-funded alcohol and other drug treatment services provided just under 210,000 treatment episodes to an estimated 130,000 clients. The four most common drugs that led clients to seek treatment were alcohol (34% of all treatment episodes), amphetamines (25%), cannabis (21%) and heroin (5%). Two-thirds (66%) of all clients receiving treatment were male and the median age of clients was 34 years (AIHW)
National Drug Treatment Reporting System 2011-2017 drug data
Latest figures from the Health Research Board show 63,303 cases* presented for treatment for problem drug use (excluding alcohol) between 2011 and 2017. The number of treated cases increased from 8,361 in 2011 to 9,892 in 2015, and then decreased to 8,922 in 2017
National Opioid Pharmacotherapy Statistics Annual Data collection (NOPSAD) 2018
On a snapshot day in 2018, just over 50,000 clients received pharmacotherapy treatment for their opioid dependence at 2,852 dosing points across Australia. There were 3,168 authorised prescribers of opioid pharmacotherapy drugs (AIHW)
Withdrawal Management Services in Canada: The National Treatment Indicators Report (PDF)
The report provides an overview of the use of WM services in Canada in 2015–2016, including episodes of care offered within specialized community-based services and in hospitals (CCSA)
Drug treatment systems in the Western Balkans: outcomes of a joint EMCDDA-UNODC survey of drug treatment facilities
This report presents a summary of the key findings from drug treatment facility surveys carried out in 2017 in Albania, Bosnia and Herzegovina, Serbia and the territory of Kosovo. The results provide insight into the characteristics and capacity of the treatment systems, as well as the availability and provision of treatment intervention (EMCDDA)
Survivors of Multiple Disadvantage Discuss Service & Support (PDF)
A report by Peer Researchers for the National Commission on Domestic and Sexual Violence and Multiple Disadvantage
Drug misuse in over 16s: opioid detoxification
2019 surveillance of drug misuse in over 16s: opioid detoxification (NICE guideline CG52)
Alcohol and drug treatment in secure settings: statistics summary 2017 to 2018
This National Drug Treatment Monitoring System (NDTMS) statistics report presents information on specialist treatment interventions for drugs and alcohol misuse in secure settings during 2017 to 2018 (public Health England)
Alcohol and drug misuse prevention and treatment guidance
Information and other resources to support commissioners, service providers and others providing alcohol and drug interventions (PHE)
Examining the efficacy of the Building Skills for Recovery programme for substance misusing offenders in custody
A study looking at the efficacy of the Building Skills for Recovery (BSR) Programme for substance-misusing offenders in custody in England and Wales (Ministry of Justice)
Just Maintaining the Status Quo?
The experience of long-term participants in Methadone Maintenance Treatment – PDF (dun Laoghaire rathdown drug and alcohol Task force)
Substance misuse treatment for young people: statistics 2017 to 2018
Alcohol and drug treatment data for under-18s from PHE’s national drug treatment monitoring system (NDTMS)
Considering Heroin-Assisted Treatment and Supervised Drug Consumption Sites in the United States
Data for 2017 indicate that there were more than 47,000 opioid-involved overdose deaths, and one in eight adults now reports having had a family member or close friend die from opioids. Increasing the availability and reducing the costs of approved medications for those with an opioid use disorder (OUD) is imperative; however, jurisdictions addressing OUDs and overdose may wish to consider additional interventions. Download (RAND)
Continuity of care for prisoners who need substance misuse treatment
An audit toolkit and guidance on data recording, for prison and community treatment providers and commissioners (Public Health England)
Guidance for drug and alcohol treatment providers and clients
Guidelines for drug and alcohol treatment providers on sharing client’s information with the National Drug and alcohol Treatment Monitoring System (NDTMS)
National Naloxone Programme Scotland Monitoring Report 2017/18 (PDF)
A total of 8,397 take-home naloxone kits were issued in Scotland in 2017/18, an increase of 3% from the previous year (NHS National Services Scotland)
Mental Health of Children and Young People in England, 2017
This survey series provides England’s best source of data on trends in child mental health. [Includes data on alcohol and drug use in the chapter on Behaviours, lifestyles and identities (NHS)
Hepatitis C treatment monitoring in England
Preliminary findings from the Hepatitis C patient registry and treatment outcome system (Public Health England)
Data on clients seen at drug and alcohol treatment agencies.
April to June 2018 (Welsh Government)
Substance misuse treatment for adults: statistics 2017 to 2018
Statistics on alcohol and drug misuse treatment for adults from PHE’s national drug treatment monitoring system (Public Health England)
20 years of the Methadone Treatment Protocol in Ireland
This is an overview of the ICGP Substance Misuse Programme as it has developed with particular reference to the 20 years of the Methadone Treatment Protocol which came into effect October 1998 (Irish College of General Practitioners)
Alcohol, drugs and tobacco: commissioning support pack
Annual guidance on smoking, drinking and drug misuse for commissioners of tobacco control, drug and alcohol services for adults and young people (Public Health England)
5-Point Strategy To Combat the Opioid Crisis
HHS has a comprehensive strategy to empower local communities on the frontlines. The opioid epidemic is one of the Department’s top priorities. In 2017, HHS launched a 5-point Opioid Strategy
Best Practices across the Continuum of Care for the Treatment of Opioid Use Disorder (PDF)
disorder in Canada should have access to comprehensive treatment options that meet all their needs. Best Practices across the Continuum of Care for the Treatment of Opioid Use Disorder presents services that should be available to individuals experiencing or at risk of experiencing harms from opioid use (CCSA)
Alcohol and drug misuse prevention and treatment guidance
Information and other resources to support commissioners, service providers and others providing alcohol and drug interventions (Public Health England)
Heroin On Trial
Presentations from the conference (SSA)
The public health burden of alcohol: evidence review
This review looks at the impact of alcohol on the public health and the effectiveness of alcohol control policies (Public Health England)
Key Findings from RAND Health’s Research on Opioid Policy
This policy brief highlights key findings from RAND research on opioid-related issues across a spectrum of policy areas including prevention, treatment, quality of care, and supply (RAND)
Health and Justice Annual Review 2017/18
While this report highlights some of the key developments and projects undertaken by the team over the course of the last financial year, it is not intended to describe every aspect of the national Health and Justice work programme
Overlap between youth justice supervision and alcohol and other drug treatment services: 1 July 2012 to 30 June 2016
Compared with the age-equivalent Australian population, those who had youth justice supervision were 30 times as likely to have an alcohol and other drug treatment service, and those who received an alcohol and other drug treatment service were 30 times as likely to have youth justice supervision (AIHW)
Drug and alcohol treatment outcomes: measuring effectiveness
Outcome monitoring forms and guidance on how alcohol and drug treatment outcomes information is collected and how it can be used to improve local services (Public Health England)
Secure setting drug and alcohol treatment business definitions
Business definitions for secure setting drug and alcohol treatment providers to input data onto the national drug treatment monitoring system (NDTMS)
Scottish Drug Misuse Database (PDF)
Overview of Initial Assessments for Specialist Drug Treatment 2016/17 (NHS Scotland)
Alcohol and Other Drug Treatment Services in Australia 2016–17
In 2016–17, 836 publicly-funded alcohol and other drug treatment services provided just over 200,000 treatment episodes to an estimated 127,000 clients (AIHW)
Factsheet: cannabis for medicinal use
Home Office UK
Medicinal cannabis – guidance documents
A range of organisations from across Australia were involved in developing the guidance documents (DoH Australia)
Our Life, Our Voice, Our Say (PDF)
Applying a Public Sector Equality and Human Rights Duty Approach to the Human Rights and Equality Issues Identified by Service Users of Opioid Treatment Services (CAN)
Our Life, Our Voice, Our Say (PDF)
Applying a Public Sector Equality and Human Rights Duty Approach to the Human Rights and Equality Issues Identified by Service Users of Opioid Treatment Services (CAN)
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 9
- Next Page »
